Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Immunology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Atopic Dermatitis Clinical Trials

A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (11) clinical trials

The objective of this study is to investigate if the study medication is effective in reducing eczema symptoms for those with moderate to severe eczema. This is a 65-week study with up to 17 office visits.  

Phase

A research study is evaluating an investigational medication used in combination with topical therapy for adults with moderate to severe eczema (atopic dermatitis).  

Phase N/A

A research study is now underway in San Diego to evaluate an investigational medication for those who have failed to respond to prior treatments for Eczema, also known as Atopic Dermatitis. If you are interested in participating in our Eczema (Atopic Dermatitis) study, please fill out the form below or ...

Phase N/A

The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.

Phase

The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.

Phase

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

This study will assess the efficacy and safety of MSTT1041A in participants with moderate to severe atopic dermatitis (AD). The study consists of a screening period, a 16-week treatment period, and an 8-week follow-up period.

Phase

A Study to Evaluate Risankizumab in Adult and Adolescent Subjects With Moderate to Severe Atopic Dermatitis

The purpose of this study is to assess the safety and efficacy of risankizumab for the treatment of moderate to severe atopic dermatitis (AD) in adult and adolescent subjects.

Phase

Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis

The maximum study duration will be 33 weeks per patient, including a screening period of up to 5 weeks, a 16-week randomized treatment period, and a 12-week follow-up period.

Phase

Steroid-reducing Effects of Crisaborole

Atopic dermatitis (AD) is a chronic skin disease and a common affliction among children. Twice daily topical corticosteroid (TCS) use over several weeks is recommended for active inflammatory disease. Side effects of TCS range from cutaneous atrophy to hypothalamic-pituitary-adrenal axis suppression. Steroid phobia and misunderstanding often lead to poor compliance ...

Phase

A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Subjects With Atopic Dermatitis (AD)

Asses the pharmacokinetics and safety of nemolizumab in adolescent subjects with AD.

Phase